HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Late Infantile Metachromatic Leukodystrophy Due to Novel Pathogenic Variants in the PSAP Gene.

Abstract
Impairment of saposin B causes rare atypical metachromatic leukodystrophy (MLD). It is encoded (together with saposin A, C, and D) by the PSAP gene. Only ten pathogenic variants were described in the PSAP gene in MLD patients to date. We report on two novel variants in the PSAP gene - c.679_681delAAG in the saposin B encoding exon 6 and c.1268delT in the saposin D encoding exon 11 in a patient with MLD. We discuss the fact, that variants resulting in PSAP null allele can be shared in patients with the deficit of other saposins (A-D) or whole prosaposin. The patient's phenotype depends then on the nature of the second allele - atypical Gaucher disease in case of saposin A, MLD in case of saposin B, and Krabbe disease in case of saposin C impairing mutations. The clinically most severe prosaposin deficit is caused by the presence of two PSAP null alleles. Thus, the assessment of a variant impact is needed to prevent delayed diagnosis or misdiagnosis in patients with PSAP mutations.
AuthorsMiriam Kolnikova, Petra Jungova, Martina Skopkova, Tomas Foltan, Daniela Gasperikova, Slavomira Mattosova, Jan Chandoga
JournalJournal of molecular neuroscience : MN (J Mol Neurosci) Vol. 67 Issue 4 Pg. 559-563 (Apr 2019) ISSN: 1559-1166 [Electronic] United States
PMID30632081 (Publication Type: Case Reports, Journal Article)
Chemical References
  • PSAP protein, human
  • Saposins
Topics
  • Exons
  • Humans
  • Infant
  • Leukodystrophy, Metachromatic (genetics, pathology)
  • Loss of Function Mutation
  • Male
  • Phenotype
  • Saposins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: